General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews.

MLA

Mohiuddin, Mohammed, et al. “General Risks of Harm with Cannabinoids, Cannabis, and Cannabis-Based Medicine Possibly Relevant to Patients Receiving These for Pain Management: An Overview of Systematic Reviews.” PAIN, vol. 162, July 2021, pp. S80–96. EBSCOhost, https://doi.org/10.1097/j.pain.0000000000002000.

APA

Mohiuddin, M., Blyth, F. M., Degenhardt, L., Di Forti, M., Eccleston, C., Haroutounian, S., Moore, A., Rice, A. S. C., Wallace, M., Park, R., & Gilron, I. (2021). General risks of harm with cannabinoids, cannabis, and cannabis-based medicine possibly relevant to patients receiving these for pain management: an overview of systematic reviews. PAIN, 162, S80–S96. https://doi.org/10.1097/j.pain.0000000000002000

Chicago

Mohiuddin, Mohammed, Fiona M. Blyth, Louisa Degenhardt, Marta Di Forti, Christopher Eccleston, Simon Haroutounian, Andrew Moore, et al. 2021. “General Risks of Harm with Cannabinoids, Cannabis, and Cannabis-Based Medicine Possibly Relevant to Patients Receiving These for Pain Management: An Overview of Systematic Reviews.” PAIN 162 (July): S80–96. doi:10.1097/j.pain.0000000000002000.